Agreement and Precision of Capstesia, a New Smarphone Application for PPV and CO Monitoring

NCT03137901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2019-11-26

No results posted yet for this study

Summary

This study test the agreement and precision of Pulse Pressure Variation (PPV) and Cardiac Output (CO) obtained by the Android application Capstesia™ against another pulse contour CO monitoring ( EV-1000, Edwards Lefesciences, USA)

Conditions

  • Surgery

Interventions

DEVICE

Capstesia

Picture of the arterial waveform taken with a smartphone

Sponsors & Collaborators

  • Erasme University Hospital

    lead OTHER

Principal Investigators

  • Alexandre Joosten, M.D · Erasme

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-10
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03137901 on ClinicalTrials.gov